265 related articles for article (PubMed ID: 23155437)
21. Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential.
Maciuszek M; Cacace A; Brennan E; Godson C; Chapman TM
Eur J Med Chem; 2021 Mar; 213():113167. PubMed ID: 33486199
[TBL] [Abstract][Full Text] [Related]
22. What regulates placental steroidogenesis in 90-day pregnant ewes?
Weems YS; Kim L; Tsuda V; Yin C; Weems CW
Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):54-65. PubMed ID: 17643888
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin (PG) FP and EP1 receptors mediate PGF2alpha and PGE2 regulation of interleukin-1beta expression in Leydig cell progenitors.
Walch L; Clavarino E; Morris PL
Endocrinology; 2003 Apr; 144(4):1284-91. PubMed ID: 12639911
[TBL] [Abstract][Full Text] [Related]
24. A role for lipoxin A₄ as an anti-inflammatory mediator in the human endometrium.
Macdonald LJ; Boddy SC; Denison FC; Sales KJ; Jabbour HN
Reproduction; 2011 Aug; 142(2):345-52. PubMed ID: 21555360
[TBL] [Abstract][Full Text] [Related]
25. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.
Chiang N; Serhan CN; Dahlén SE; Drazen JM; Hay DW; Rovati GE; Shimizu T; Yokomizo T; Brink C
Pharmacol Rev; 2006 Sep; 58(3):463-87. PubMed ID: 16968948
[TBL] [Abstract][Full Text] [Related]
26. Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation.
Parkinson JF
Inflamm Allergy Drug Targets; 2006 Apr; 5(2):91-106. PubMed ID: 16613568
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity.
Simiele F; Recchiuti A; Mattoscio D; De Luca A; Cianci E; Franchi S; Gatta V; Parolari A; Werba JP; Camera M; Favaloro B; Romano M
FASEB J; 2012 Mar; 26(3):1323-33. PubMed ID: 22131270
[TBL] [Abstract][Full Text] [Related]
28. Airway lipoxin A4/formyl peptide receptor 2-lipoxin receptor levels in pediatric patients with severe asthma.
Gagliardo R; Gras D; La Grutta S; Chanez P; Di Sano C; Albano GD; Vachier I; Montalbano AM; Anzalone G; Bonanno A; Riccobono L; Gjomarkaj M; Profita M
J Allergy Clin Immunol; 2016 Jun; 137(6):1796-1806. PubMed ID: 26971688
[TBL] [Abstract][Full Text] [Related]
29. Lipoxin A₄-mediated KATP potassium channel activation results in cystic fibrosis airway epithelial repair.
Buchanan PJ; McNally P; Harvey BJ; Urbach V
Am J Physiol Lung Cell Mol Physiol; 2013 Jul; 305(2):L193-201. PubMed ID: 23686859
[TBL] [Abstract][Full Text] [Related]
30. Lipoxin Signaling in Murine Lung Host Responses to Cryptococcus neoformans Infection.
Colby JK; Gott KM; Wilder JA; Levy BD
Am J Respir Cell Mol Biol; 2016 Jan; 54(1):25-33. PubMed ID: 26039320
[TBL] [Abstract][Full Text] [Related]
31. ALX/FPR2 Modulates Anti-Inflammatory Responses in Mouse Submandibular Gland.
Wang CS; Wee Y; Yang CH; Melvin JE; Baker OJ
Sci Rep; 2016 Apr; 6():24244. PubMed ID: 27064029
[TBL] [Abstract][Full Text] [Related]
32. Lipoxin A₄ modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanism.
Ramon S; Bancos S; Serhan CN; Phipps RP
Eur J Immunol; 2014 Feb; 44(2):357-69. PubMed ID: 24166736
[TBL] [Abstract][Full Text] [Related]
33. Expression of lipoxin A4, TNFα and IL-1β in maternal peripheral blood, umbilical cord blood and placenta, and their significance in pre-eclampsia.
Dong W; Yin L
Hypertens Pregnancy; 2014 Nov; 33(4):449-56. PubMed ID: 24960456
[TBL] [Abstract][Full Text] [Related]
34. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32.
Lee HJ; Park MK; Lee EJ; Lee CH
Int J Biochem Cell Biol; 2013 Dec; 45(12):2801-7. PubMed ID: 24120851
[TBL] [Abstract][Full Text] [Related]
35. Functions of resolvin D1-ALX/FPR2 receptor interaction in the hemoglobin-induced microglial inflammatory response and neuronal injury.
Liu GJ; Tao T; Wang H; Zhou Y; Gao X; Gao YY; Hang CH; Li W
J Neuroinflammation; 2020 Aug; 17(1):239. PubMed ID: 32795323
[TBL] [Abstract][Full Text] [Related]
36. Focal experimental injury leads to widespread gene expression and histologic changes in equine flexor tendons.
Jacobson E; Dart AJ; Mondori T; Horadogoda N; Jeffcott LB; Little CB; Smith MM
PLoS One; 2015; 10(4):e0122220. PubMed ID: 25837713
[TBL] [Abstract][Full Text] [Related]
37. Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35.
Qin CX; Norling LV; Vecchio EA; Brennan EP; May LT; Wootten D; Godson C; Perretti M; Ritchie RH
Br J Pharmacol; 2022 Oct; 179(19):4617-4639. PubMed ID: 35797341
[TBL] [Abstract][Full Text] [Related]
38. Dual role of lipoxin A4 in pneumosepsis pathogenesis.
Sordi R; Menezes-de-Lima O; Horewicz V; Scheschowitsch K; Santos LF; Assreuy J
Int Immunopharmacol; 2013 Oct; 17(2):283-92. PubMed ID: 23816538
[TBL] [Abstract][Full Text] [Related]
39. Effects of the ALX/FPR2 receptors of lipoxin A
Gan N; Zhang R; Xu X; Wang Y; Qi A; Zhang Y; Wang A
Biomed Pharmacother; 2019 Apr; 112():108595. PubMed ID: 30784911
[TBL] [Abstract][Full Text] [Related]
40. microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A
Pierdomenico AM; Patruno S; Codagnone M; Simiele F; Mari VC; Plebani R; Recchiuti A; Romano M
Sci Rep; 2017 Oct; 7(1):13519. PubMed ID: 29044225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
